215 related articles for article (PubMed ID: 16546462)
21. The usefulness of power Doppler ultrasonography for diagnosing prostate cancer: histological correlation of each biopsy site.
Franco OE; Arima K; Yanagawa M; Kawamura J
BJU Int; 2000 Jun; 85(9):1049-52. PubMed ID: 10848692
[TBL] [Abstract][Full Text] [Related]
22. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml.
Kumar V; Jagannathan NR; Kumar R; Thulkar S; Gupta SD; Hemal AK; Gupta NP
NMR Biomed; 2007 Feb; 20(1):11-20. PubMed ID: 16894640
[TBL] [Abstract][Full Text] [Related]
23. Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy.
Hofer C; Laubenbacher C; Block T; Breul J; Hartung R; Schwaiger M
Eur Urol; 1999; 36(1):31-5. PubMed ID: 10364652
[TBL] [Abstract][Full Text] [Related]
24. Value of transrectal ultrasound in identifying local disease after radical prostatectomy.
Kapoor DA; Wasserman NF; Zhang G; Reddy PK
Urology; 1993 Jun; 41(6):594-7. PubMed ID: 7685958
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of transrectal power-Doppler ultrasonography and effect of contrast-enhancement for detecting prostate cancer].
Saito S
Nihon Hinyokika Gakkai Zasshi; 2002 May; 93(4):562-7. PubMed ID: 12056041
[TBL] [Abstract][Full Text] [Related]
26. MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy.
Silverman JM; Krebs TL
AJR Am J Roentgenol; 1997 Feb; 168(2):379-85. PubMed ID: 9016212
[TBL] [Abstract][Full Text] [Related]
27. Radical prostatectomy: transrectal sonographic evaluation to assess for local recurrence.
Salomon CG; Flisak ME; Olson MC; Dudiak CM; Flanigan RC; Waters WB
Radiology; 1993 Dec; 189(3):713-9. PubMed ID: 7694311
[TBL] [Abstract][Full Text] [Related]
28. Sensitivity of computed tomography in detecting local recurrence of prostatic carcinoma following radical prostatectomy.
Krämer S; Görich J; Gottfried HW; Riska P; Aschoff AJ; Rilinger N; Brambs HJ; Sokiranski R
Br J Radiol; 1997 Oct; 70(838):995-9. PubMed ID: 9404201
[TBL] [Abstract][Full Text] [Related]
29. Clinical evaluation of transrectal power doppler imaging in the detection of prostate cancer.
Inahara M; Suzuki H; Nakamachi H; Kamiya N; Shimbo M; Komiya A; Ueda T; Ichikawa T; Akakura K; Ito H
Int Urol Nephrol; 2004; 36(2):175-80. PubMed ID: 15368688
[TBL] [Abstract][Full Text] [Related]
30. [Yield of ultrasonography-guided transrectal biopsy in the diagnosis of carcinoma of the prostate].
Fernández González I; Ruiz Rubio JL; Llorente Abarca C; Aramburu González JA; Montes Díaz MJ; Herrero Payo A; Sánchez Sánchez E; Berenguer Sánchez A
Arch Esp Urol; 1995; 48(6):587-94. PubMed ID: 7544968
[TBL] [Abstract][Full Text] [Related]
31. Correlation of transrectal ultrasound imaging and the results of systematic biopsy with pathological examination of radical prostatectomy specimens.
Gohji K; Morisue K; Kizaki T; Fujii A
Br J Urol; 1995 Jun; 75(6):758-65. PubMed ID: 7613834
[TBL] [Abstract][Full Text] [Related]
32. Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesions.
Cornud F; Belin X; Piron D; Chrétien Y; Flam T; Casanova JM; Hélénon O; Méjean A; Thiounn N; Moreau JF
Urology; 1997 May; 49(5):709-15. PubMed ID: 9145975
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of power Doppler ultrasonography for prostate biopsy in men with elevated serum prostate specific antigen levels.
Ho CC; Khor TW; Singam P; Goh EH; Tan GH; Bahadzor B; Zulkifli MZ
Clin Ter; 2012; 163(3):211-4. PubMed ID: 22964693
[TBL] [Abstract][Full Text] [Related]
34. Transrectal ultrasound in detecting prostate cancer compared with serum total prostate-specific antigen levels.
Tamsel S; Killi R; Hekimgil M; Altay B; Soydan S; Demirpolat G
J Med Imaging Radiat Oncol; 2008 Feb; 52(1):24-8. PubMed ID: 18373822
[TBL] [Abstract][Full Text] [Related]
35. Limitations of transperineal ultrasound-guided prostate biopsies.
Shinghal R; Terris MK
Urology; 1999 Oct; 54(4):706-8. PubMed ID: 10510932
[TBL] [Abstract][Full Text] [Related]
36. 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse.
Oyama N; Miller TR; Dehdashti F; Siegel BA; Fischer KC; Michalski JM; Kibel AS; Andriole GL; Picus J; Welch MJ
J Nucl Med; 2003 Apr; 44(4):549-55. PubMed ID: 12679398
[TBL] [Abstract][Full Text] [Related]
37. Prostate cancer volume estimations based on transrectal ultrasonography-guided biopsy in order to predict clinically significant prostate cancer.
Konyalioglu E; Tarhan H; Cakmak O; Pala EE; Zorlu F
Int Braz J Urol; 2015; 41(3):442-8. PubMed ID: 26200537
[TBL] [Abstract][Full Text] [Related]
38. [The digital rectal exam, prostate-specific antigen and transrectal echography in the diagnosis of prostatic cancer].
Martínez de Hurtado J; Chéchile Toniolo G; Villavicencio Mavrich H
Arch Esp Urol; 1995 Apr; 48(3):247-59. PubMed ID: 7538749
[TBL] [Abstract][Full Text] [Related]
39. [Possibilities of using magnetic resonance imaging-transrectal ultrasound fusion in the diagnosis of recurrent prostate cancer].
Kapustin VV
Vestn Rentgenol Radiol; 2011; (3):53-6. PubMed ID: 22288135
[TBL] [Abstract][Full Text] [Related]
40. Colour Doppler ultrasonography for detecting perineural invasion (PNI) and the value of PNI in predicting final pathological stage: a prospective study of men with clinically localized prostate cancer.
Kravchick S; Cytron S; Peled R; Ben-Dor D; Kravchenko Y
BJU Int; 2003 Jul; 92(1):28-31. PubMed ID: 12823378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
